Clinical Trials
20
Active:0
Completed:14
Trial Phases
4 Phases
Phase 1:2
Phase 3:11
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
Phase 3
11 (57.9%)Not Applicable
3 (15.8%)Phase 1
2 (10.5%)Phase 4
2 (10.5%)phase_1_2
1 (5.3%)Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2022-03-03
- Lead Sponsor
- Venus Remedies Limited
- Target Recruit Count
- 24
- Registration Number
- NCT05265676
- Locations
- 🇮🇳
Cliantha Research Limited, Ahmedabad, Gujarat, India
CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria
Phase 3
Completed
- Conditions
- Acute PyelonephritisUrinary Tract Infection Complicated
- Interventions
- First Posted Date
- 2018-03-26
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- Venus Remedies Limited
- Target Recruit Count
- 230
- Registration Number
- NCT03477422
- Locations
- 🇮🇳
Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Srinagar, Jammu & Kashmir, India
🇮🇳Sapthagiri Institute of Medical Sciences and Research Center, Bangalore, Karnataka, India
🇮🇳KLES, Dr Prabhakar Kore Hospital and Medical Centre , , India, Belgaum, Karnataka, India
News
No news found